Suboxone

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 12496-1202
  • Package NDC 12496-1202-3
  • Application number NDA022410
  • SPL ID ad5a289a-6285-4b2d-b7ad-e4812169dd58
  • SPL set ID 8a5edcf9-828c-4f97-b671-268ab13a8ecd
  • UNII 56W8MW3EN1
  • UNII F850569PQR
  • RxCUI 1010600
  • RxCUI 1010603
  • RxCUI 1010604
  • RxCUI 1010606
  • RxCUI 1307056
  • RxCUI 1307058
  • RxCUI 1307061
  • RxCUI 1307063

What the source publishes

Labeler
INDIVIOR INC.
Active ingredients
buprenorphine hydrochloride, naloxone hydrochloride
Form
FILM, SOLUBLE
Routes
BUCCAL, SUBLINGUAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:12496-1202_ad5a289a-6285-4b2d-b7ad-e4812169dd58
{
  "name": "Suboxone",
  "splId": "ad5a289a-6285-4b2d-b7ad-e4812169dd58",
  "labels": [
    {
      "setId": "8a5edcf9-828c-4f97-b671-268ab13a8ecd",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8a5edcf9-828c-4f97-b671-268ab13a8ecd",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8a5edcf9-828c-4f97-b671-268ab13a8ecd"
    }
  ],
  "routes": [
    "BUCCAL",
    "SUBLINGUAL"
  ],
  "labeler": "INDIVIOR INC.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 POUCH in 1 CARTON (12496-1202-3)  / 1 FILM, SOLUBLE in 1 POUCH (12496-1202-1)",
      "package_ndc": "12496-1202-3",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20100913"
    }
  ],
  "productId": "12496-1202_ad5a289a-6285-4b2d-b7ad-e4812169dd58",
  "useDomain": "unknown",
  "dosageForm": "FILM, SOLUBLE",
  "productNdc": "12496-1202",
  "deaSchedule": "CIII",
  "genericName": "buprenorphine hydrochloride, naloxone hydrochloride",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "BUPRENORPHINE HYDROCHLORIDE",
      "strength": "2 mg/1"
    },
    {
      "name": "NALOXONE HYDROCHLORIDE",
      "strength": ".5 mg/1"
    }
  ],
  "applicationNumber": "NDA022410",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20100913",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0312496120835"
    ],
    "unii": [
      "56W8MW3EN1",
      "F850569PQR"
    ],
    "rxcui": [
      "1010600",
      "1010603",
      "1010604",
      "1010606",
      "1307056",
      "1307058",
      "1307061",
      "1307063"
    ],
    "spl_set_id": [
      "8a5edcf9-828c-4f97-b671-268ab13a8ecd"
    ],
    "manufacturer_name": [
      "INDIVIOR INC."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:12496-1202_ad5a289a-6285-4b2d-b7ad-e4812169dd58"